Compare LIC MF Healthcare Fund vs HDFC Pharma And Healthcare Fund
LIC MF Healthcare Fund
EquitySectoral-Pharma
HDFC Pharma And Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
1.0
5.0
Min SIP Amount
₹200
₹100
Expense Ratio
2.72
2.11
NAV
₹37.43
₹22.82
Fund Started
08 Feb 2019
14 Sep 2023
Fund Size
₹99.36 Cr
₹3501.37 Cr
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Exit load of 1%, if redeemed within 30 days.
1 Year
12.81%
26.81%
3 Year
20.64%
29.73%
5 Year
12.29%
-
Equity
97.53%
96.77%
Cash
2.47%
3.23%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.59% |
Divi's Laboratories Ltd. | 9.07% |
Neuland Laboratories Ltd. | 6.14% |
Torrent Pharmaceuticals Ltd. | 6.04% |
Apollo Hospitals Enterprise Ltd. | 5.75% |
Aurobindo Pharma Ltd. | 5.23% |
Navin Fluorine International Ltd. | 4.98% |
Zydus Lifesciences Ltd. | 4.97% |
Aster DM Quality Care Ltd. | 4.61% |
Fortis Healthcare Ltd. | 3.77% |
Name | Assets |
|---|---|
Divi's Laboratories Ltd. | 9.39% |
Sun Pharmaceutical Industries Ltd. | 8.28% |
Alkem Laboratories Ltd. | 4.64% |
Cipla Ltd. | 4.15% |
Apollo Hospitals Enterprise Ltd. | 3.69% |
Torrent Pharmaceuticals Ltd. | 3.65% |
Max Healthcare Institute Ltd. | 3.61% |
Aster DM Quality Care Ltd. | 3.56% |
Lupin Ltd. | 3.55% |
Neuland Laboratories Ltd. | 3.24% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Launch Date
08 Feb 2019
14 Sep 2023
